Download The Contract Biomanufacturing Market Outlook to 2017 Brochure

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Marketing ethics wikipedia , lookup

First-mover advantage wikipedia , lookup

Grey market wikipedia , lookup

Market analysis wikipedia , lookup

Foreign market entry modes wikipedia , lookup

Transcript
Brochure
More information from http://www.researchandmarkets.com/reports/2498073/
The Contract Biomanufacturing Market Outlook to 2017
Description:
The volume demand for biologics active pharmaceutical ingredients (API) from 2011-2017 is set to show a
20% annual increase. Combined with a boost in biosimilars, the biologics contract manufacturing market is
forecast to grow 9% per year over the same period.
Features and benefits:
- Develop a winning expansion and outsourcing strategy to grow your market share with forecasts through
to 2017
- Assess the areas to target and use your findings to help increase profits with information on drivers and
resistors of outsourced biomanufacturing
- Use the forecast for biologic and CMO market to adapt your strategy and ensure you're commercially
successful
- With analysis on the 5 leading players you will understand what your competitors are doing and what
actions you can take to stay competitive
Highlights
The biological contract manufacturing organization (CMO) market will grow at a compound annual growth
rate (CAGR) of 9.4% between 2011 and 2017. Mammalian contract manufacturing accounted for almost two
thirds of the market in 2012, which was estimated at a size of $3bn.
Increasing API demand driven by biologics market growth and an increase in the number of late-stage
clinical trials and approved biotech products will be the biggest drivers of the bio-CMO market.
Your key questions answered:
- What is the state of contract biomanufacturing in emerging regions?
- Who are the leading bio-CMOs and what are their strategies, strengths and weaknesses?
- What is the most attractive area of investment in the biologics market?
Contents:
Overview
Catalyst
- Summary
Executive Summary
Market Overview
Definition
Segmentation
- Categories of CMOs and services offered
References
Market Dynamics
Drivers
- Growth of large molecule market
- Cost savings
- Risk reduction and risk sharing
- Lead-time saving
- Access to expertise and technology
- Orphan drugs
- Growth in emerging markets
- Biosimilars
Resistors
- Increasing yields and disposable technology
- Overcapacity and pharma’s increasing in-house capacity
- Regulatory uncertainty over biosimilars
Market forecasts
- Microbial and mammalian drug market
- Microbial vs mammalian CMO market
- Biosimilars
- Biomanufacturing installed base
Contract biomanufacturing in emerging regions
References
Leading Players
Summary
Introduction
Boehringer Ingelheim
- Overview and capabilities
- Partnerships, deals, and expansion plans
- SWOT analysis
Lonza
- Overview and capabilities
- Partnerships, deals, and expansion plans
- SWOT analysis
Sandoz
- Overview and capabilities
- Partnerships, deals, and expansion plans
- SWOT analysis
Fujifilm Diosynth Biotechnologies
- Overview and capabilities
- Partnerships, deals, and expansion plans
- SWOT analysis
DSM
- Overview and capabilities
- Partnerships, deals, and expansion plans
- SWOT analysis
References
Appendix
Methodology
- Pharmaceutical market
- Bio-CMO market
References
Table 1: Categories of CMOs and services offered
Figure 1: Biopharma value chain
Figure 2: Small vs large molecule pharma market ($bn), 2008–17
Figure 3: Number of orphan drug NMEs historically and forecasted average in the US, 2005–16
Figure 4: Biopharmaceutical drug market by major product group ($bn), 2011–17
Figure 5: Mammalian and microbial API CMO market ($bn), 2010–17
Figure 6: Comparison of leading bio-CMOs by capability
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2498073/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
The Contract Biomanufacturing Market Outlook to 2017
Web Address:
http://www.researchandmarkets.com/reports/2498073/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 3500
Electronic (PDF) Enterprisewide:
USD 8750
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World